Latest News and Press Releases

Rowlett, TX, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Right on Brands, Inc. (OTC PINK: RTON), a fully reporting SEC filer and developer of a broad line of hemp-based smokables, beverages, tinctures, and...

Dallas, TX, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Right on Brands, Inc. (OTC PINK: RTON), a fully reporting SEC filer and developer of a broad line of hemp-based smokables, beverages, tinctures, and...

Dallas, TX, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Right on Brands, Inc. (OTC PINK: RTON) a fully reporting SEC filer and developer of a broad line of hemp-based smokables, beverages, tinctures, and...

Dalles, Texas, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Right on Brands, Inc. (OTC PINK: RTON), a fully reporting SEC filer and developer of a broad line of hemp-based smokables, beverages, tinctures, and...

Dallas, Texas, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Right on Brands, Inc.™ (OTC Pink: RTON), a fully reporting SEC filer and developer of a broad line of hemp-based foods, beverages, tinctures, and...

NEW YORK, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of...

Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada DUBLIN and LUGANO, July 31, 2019 -- Endo International plc (NASDAQ: ENDP),  and Helsinn, a Swiss...

SAN DIEGO, March 07, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF)  today announced that its joint venture partner’s, (Emerald Health Bioceuticals or...

VICTORIA, British Columbia, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF)  today announced that its joint venture partner, San Diego-based...

Detroit, Michigan, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Investors for Opioid Accountability (IOA), a coalition of 53 institutional investors with over $3.4 trillion in assets, commends Endo...